Extract Galanthamine Hydrobromide Powder Pharmaceutical Chemical Galanthamine Hbr Powder Galanthamine Hydrobromide

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Solid
• Purity: >99%
• Model NO.: D-sung Galanthamine hydrobromide
• Product Name: Galantamine Hydrobromide
• Name: Galantamine Hbr
• Appearance: White Powder
• Color: White
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Pharmaceutical Grade
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 1953-04-4
• Molecular Weigh: 368.26500
• Mf: C17h22brno3
• Flash Point: 439.3
• Melting Point: 256
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-sung
• Origin: Shaanxi Xi′an
• HS Code: 29399990
• Production Capacity: 100kg/Month

Product Description

 

Product Description

Extract Galanthamine hydrobromide powder Pharmaceutical Chemical Galanthamine Hbr powder Galanthamine hydrobromide
 

 

Product Description

 

 

Product Datails

 

 

Model NO.	Galantamine Hydrobromide
Appearance	White Powder
CAS	1953-04-4
MW	368
Mf	C17h22brno3

Galantamine (also called galanthamine, marketed as Reminyl (Janssen)) can be isolated from several plants, including daffodil bulbs, and now synthesized. Galantamine is a specific, competitive, and reversible acetylcholinesterase inhibitor. It is also an allosteric modulator at nicotinic cholinergic receptor sites potentiating cholinergic nicotinic neurotransmission. A small number of early studies showed mild cognitive and global benefits for patients with Alzheimer's disease, and recently several multicentre clinical trials have been published with positive findings. Galantamine has received regulatory approval in Sweden, is available in Austria, and awaits marketing approval in the United States, Europe, and other countries.

Application&Function

 

 

 

 

1.Anti-cholinesterase.
2.Stimulate and inhibit acetylcholinesterase, regulate intracephalic nicotine receptor position.
3.Cures the infantile paralysis sequelae, sweeny and myasthenia gravis pseudoparalytica, etc.
4.Improve the recognition function of light, mild Alzheimer disease patients significantly,
and delay the process of function decrease of brain cells.
5.Improve the conduction between nerve and muscle.

Specification